Header Logo

Connection

ERNEST HAWK to Drug Approval

Back to Details
This is a "connection" page, showing publications ERNEST HAWK has written about Drug Approval.
ERNEST HAWK
Connection Strength
0.013
Drug Approval
  1. Counterpoint: Because some surrogate end point biomarkers measure the neoplastic process they will have high utility in the development of cancer chemopreventive agents against sporadic cancers. Cancer Epidemiol Biomarkers Prev. 2003 Jul; 12(7):593-6.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.